Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Before you respond

  • Federal grantsHow to Find Grants for Nonprofits
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to apply for a grantGrant Applications vs. RFPs: Writing Differences Explained
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Bids
  3. ›Federal
  4. ›Pilot and Feasibility Studies in Preparation for Substance…

U.S. National Institutes of Health·United States of America

Pilot and Feasibility Studies in Preparation for Substance Use and HIV Prevention Intervention and Services Research Trials (R34 Clinical Trial Optional)

Closes 7/16/2029$100k – $450kGrants Notice
Get bids like this by emailBid source

Description

This NIH Funding Opportunity (PAR‑28‑093) invites applications for R34 planning grants to conduct pilot and feasibility studies that will lay the groundwork for larger efficacy, effectiveness, or services‑research trials targeting substance‑use prevention, treatment, recovery, and HIV‑related interventions. Eligible applicants include a broad range of public, nonprofit, tribal, and for‑profit entities (including foreign organizations) that can partner with end‑users such as policymakers, practitioners, and people with lived experience. Projects may focus on: • Development or adaptation of behavioral or biomedical interventions to prevent substance use or HIV transmission; • Evaluation of service delivery models, including comorbid pain, mental‑health, or medical conditions; • Implementation science studies to assess acceptability, feasibility, and scalability; • Creation of measurement tools, protocols, or data‑collection methods for future trials. No preliminary data required, but a clear theory of change or logic model is expected. The award ceiling is $450,000; the application window opens Jan 16 2027 and closes Jul 16 2029.

Attached files

Contact

Nawall Kertache(Program Staff)

[email protected]

(877) 464-4772

Key dates

Opened
1/26/2026
Closes
7/16/2029
Projected award
7/1/2027
Duration
4 years

Last updated

Details

Type
Grants Notice
Industry
Healthcare and Medical Services
NAICS
541714
Solicitation №
PAR-28-093

Budget estimate

$100,000 – $450,000

The NOFO lists an award ceiling of $450,000 and does not specify a minimum. Pilot grants of this type typically range from $100K (for very small feasibility studies) to the full ceiling for more extensive multi‑site pilots. Therefore, a realistic budget range is roughly $100,000 to $450,000, depending on scope, number of sites, and level of effort proposed.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one. Bid Banana has 1.6M+ bids and awards.

You found this bid by looking. Bid Banana searches open government bids across all 50 states, updated daily, so you stop hunting: save a search once and we email you your new matches, daily or weekly.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. National Institutes of Health·United States of America

Top match · 89%

Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)

Closes 3/16/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

89% match

HIV Prevention and Alcohol (R61/R33 Clinical Trials Optional)

Closes 9/6/2027Opened 10/1/2026

U.S. National Institutes of Health·United States of America

89% match

Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)

Closes 10/27/2027Opened 5/11/2021

U.S. National Institutes of Health·United States of America

89% match

Implementation Science to Advance HIV Prevention, Treatment, and Care (R61/R33 Clinical Trial Optional)

Closes 6/20/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

89% match

High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)

Closes 3/6/2027Opened 8/2/2024

U.S. National Institutes of Health·United States of America

87% match

Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)

Closes 10/28/2027Opened 6/9/2025

U.S. National Institutes of Health·United States of America

87% match

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)

Closes 11/17/2026Opened 12/20/2023

U.S. National Institutes of Health·United States of America

87% match

High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional)

Closes 3/5/2027Opened 1/17/2024

U.S. National Institutes of Health·United States of America

87% match

Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)

Closes 12/3/2027Opened 12/5/2024

U.S. National Institutes of Health·United States of America

86% match

Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34 - Clinical Trial Optional)

Closes 2/15/2027Opened 8/25/2026

U.S. National Institutes of Health·United States of America

86% match

HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)

Closes 2/9/2029Opened 6/4/2026

U.S. National Institutes of Health·United States of America

86% match

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

Closes 10/25/2027Opened 6/23/2022

U.S. National Institutes of Health·United States of America

86% match

AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

Closes 5/24/2027Opened 6/24/2026

U.S. National Institutes of Health·United States of America

86% match

NEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 3/2/2022

U.S. National Institutes of Health·United States of America

86% match

NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)

Closes 3/16/2027Opened 11/3/2023

U.S. National Institutes of Health·United States of America

86% match

Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Closes 6/16/2028Opened 3/16/2026

U.S. National Institutes of Health·United States of America

86% match

Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30 Clinical Trial Not Allowed)

Closes 5/25/2029Opened 11/18/2025

U.S. National Institutes of Health·United States of America

85% match

Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)

Closes 1/7/2028Opened 1/13/2023

U.S. National Institutes of Health·United States of America

85% match

Prevention and Treatment through a Comprehensive Care Continuum for HIV-affected Adolescents in Resource-Constrained Settings--Implementation Science Network (PATC3H-IN)

Closes 10/27/2027Opened 10/20/2026

U.S. National Institutes of Health·United States of America

85% match

Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)

Closes 11/5/2027Opened 1/8/2025

U.S. National Institutes of Health·United States of America

85% match

Assessing the Feasibility of Incorporating Mechanisms in Multi-site Clinical Trials of Mind and Body Interventions on Whole Person Health Restoration (R33 Clinical Trial Required)

Closes 11/16/2029Opened 7/8/2025

U.S. National Institutes of Health·United States of America

84% match

Feasibility Studies to Inform the Design of Future Clinical Trials

Closes 2/15/2027Opened 4/28/2026

U.S. National Institutes of Health·United States of America

84% match

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Closes 8/21/2028Opened 5/13/2025

U.S. National Institutes of Health·United States of America

84% match

Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)

Closes 10/15/2027Opened 11/26/2024

U.S. National Institutes of Health·United States of America

84% match

Early to Definitive Clinical Trials (R61/R33 Clinical Trial Required)

Closes 7/30/2027Opened 9/29/2026